Skip to main navigation
Home

Search form

  • About Us

    • Profile & Mission

    • Our Strategy

    • Leadership Team

    • Company Histroy

  • Our Products

  • Cumberland Emerging Technologies

  • Investor Relations

    Investor Relations

    • Investor Relations
    • Corporate Update
    • Corporate Governance
      • Committees
      • Contact the Board
    • Stock Information
      • Historic Stock Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Events & Presentations
    • Investor FAQs
    • Press Releases
    • Contact IR
    3 Mo. 6 Mo. 1 Yr.

    Shareholder Tools

    Search Investor Relations

  • News

  • Blog

  • Contact Us

    Corporate Headquarters

    Cumberland Pharmaceuticals Inc.
    2525 West End Avenue, Suite 950
    Nashville, Tennessee 37203

    Phone: (615) 255-0068
    Toll Free: (877) 484-2700
    Fax: (615) 255-0094

    info@cumberlandpharma.com

    *For directions to us, please see Location

    Employment Opportunities

    employment@cumberlandpharma.com

    Investor Relations

    investors@cumberlandpharma.com

    Business Development

    development@cumberlandpharma.com

    Wholesaler Customer Service

    Phone: (877) 274-7200
    Fax: (614) 652-9127

    Medical Information

    This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites.

    Adverse Event Reporting

    Toll Free Phone: (866) 767-5077
    (For healthcare professionals only)

     

     

Investor Relations

  • Investor Relations
  • Corporate Update
  • Corporate Governance
    • Committees
    • Contact the Board
  • Stock Information
    • Historic Stock Lookup
    • Ownership Profile
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Events & Presentations
  • Investor FAQs
  • Press Releases
  • Contact IR
3 Mo. 6 Mo. 1 Yr.

Shareholder Tools

Search Investor Relations

 

SEC Filings

There are no SEC filings available.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
Displaying 101 - 110 of 110 results
Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203
Site MapPrivacy PolicyTerms & Conditions